Trial Profile
Safety and Immunogenicity of Sanofi Pasteur Meningococcal (Groups A and C) Polysaccharide Vaccine Versus Lanzhou Institute for Biological Products Meningococcal (Groups A and C) Polysaccharide Vaccine in Children 2-6 Years of Age in China
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2013
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups A and C polysaccharide (Primary)
- Indications Meningococcal group A infections; Meningococcal group C infections; Meningococcal infections
- Focus Pharmacodynamics
- 16 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Sep 2011 New trial record